Stay updated on Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial page
- CheckyesterdayChange DetectedThe revision line was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew study locations have been added across the United States, Australia, and Canada and several existing sites have been removed, including the HHS Vulnerability Disclosure; the page revision is v3.3.3.SummaryDifference2%

- Check51 days agoChange DetectedPublications section updated to indicate PubMed entries are auto-filled and may not be about the study, and the revision version was updated to v3.3.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe government funding notice banner at the top of the page has been removed.SummaryDifference0.3%

- Check72 days agoChange DetectedTwo screenshots show no meaningful edits to the Study Details page (NCT03703882). Core content including eligibility criteria, study design, outcomes, and listed locations remains unchanged.SummaryDifference0.3%

- Check101 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference3%

Stay in the know with updates to Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial page.